miR-135a Reduces Osteosarcoma Pulmonary Metastasis by Targeting Both BMI1 and KLF4

Because of the modest response rate after surgery and chemotherapy, treatment of osteosarcoma (OS) remains challenging due to tumor recurrence and metastasis. miR-135a has been reported to act as an anticarcinogenic regulator of several cancers. However, its expression and function in osteosarcoma r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chenglong, Mao, Xingjia, Cheng, Caitong, Jiao, Yurui, Zhou, Yi, Ren, Tingting, Wu, Zhuangzhuang, Lv, Zhi, Sun, Xiaojuan, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019936/
https://www.ncbi.nlm.nih.gov/pubmed/33828977
http://dx.doi.org/10.3389/fonc.2021.620295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019936/
https://www.ncbi.nlm.nih.gov/pubmed/33828977
http://dx.doi.org/10.3389/fonc.2021.620295

Ejemplares similares